M. Navarro Gómez

Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients

P. Soler-Palacín, C. Fortuny, V. Briz, 2016, Medicine.

Effectiveness and safety of integrase inhibitors in HIV-infected pregnant women followed up in the Madrid Cohort.

J. T. Ramos Amador, L. P. Prieto Tato, Marta Illán Ramos, 2020, Medicina clínica (Ed. impresa).

New diagnosis of mother-to-child transmission of HIV in 8 Latin-American countries during 2018

J. Juárez, D. Estripeaut, Beatriz Ruiz Sáez, 2022, BMC Infectious Diseases.

Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinic

J. Blackstone, E. Williams, C. Giaquinto, 2023, EClinicalMedicine.